UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau

Alzheimer's & dementia, 2021-09, Vol.17 (9), p.1575-1582

2021

Volltextzugriff (PDF)

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab

Arthritis & rheumatology (Hoboken, N.J.), 2017-03, Vol.69 (3), p.643-654

2017

Volltextzugriff (PDF)

Multiple Regulatory Variants Modulate Expression of 5-Hydroxytryptamine 2A Receptors in Human Cortex

Biological psychiatry (1969), 2013-03, Vol.73 (6), p.546-554

2013

Volltextzugriff (PDF)

CYP2D6 predicted metabolizer status and safety in adult patients with attention-deficit hyperactivity disorder participating in a large placebo-controlled atomoxetine maintenance of response clinical trial

Journal of clinical pharmacology, 2015-10, Vol.55 (10), p.1167-1174

2015

Volltextzugriff (PDF)

Antipsychotic-induced gene regulation in multiple brain regions

Journal of neurochemistry, 2010-04, Vol.113 (1), p.175-187

2010

Volltextzugriff (PDF)

The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus

Neuroscience letters, 2000-10, Vol.293 (2), p.91-94

2000

Volltextzugriff (PDF)

Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia

Journal of personalized medicine, 2016-02, Vol.6 (1), p.9

2016

Volltextzugriff (PDF)

Fast Fos: rapid protocols for single- and double-labeling c-Fos immunohistochemistry in fresh frozen brain sections

Journal of neuroscience methods, 2005-01, Vol.141 (1), p.9-20

2005

Volltextzugriff (PDF)

Modulation of neurotransmitter release in orexin/hypocretin-2 receptor knockout mice: A microdialysis study

Journal of neuroscience research, 2012-03, Vol.90 (3), p.588-596

2012

Volltextzugriff (PDF)

Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates

Complex psychiatry, 2015-07, Vol.1 (2), p.82-93

2015

Volltextzugriff (PDF)

Subgroup Analyses of the Amyloid PET Substudies From EMERGE and ENGAGE, Phase 3 Clinical Trials Evaluating Aducanumab in Patients With Early Alzheimer’s Disease (P1-1.Virtual)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex

Neuropsychopharmacology (New York, N.Y.), 2003-01, Vol.28 (1), p.45-52

2003

Volltextzugriff (PDF)

CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab

Alzheimer's & dementia, 2023-08, Vol.19 (8), p.3379-3388

2023

Volltextzugriff (PDF)

Reductions in Biomarkers of Alzheimer’s Disease Pathophysiology Following Treatment With Aducanumab Were Associated With Slowing in Clinical Decline (P1-1.Virtual)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Phencyclidine-induced changes in rat cortical gene expression identified by microarray analysis: implications for schizophrenia

Neurobiology of disease, 2004-06, Vol.16 (1), p.220-235

2004

Volltextzugriff (PDF)

Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine

The Journal of pharmacology and experimental therapeutics, 2005-12, Vol.315 (3), p.1265

2005

Volltextzugriff (PDF)

Subgroup analyses of the amyloid PET substudies from EMERGE and ENGAGE, phase 3 clinical trials evaluating aducanumab in patients with early Alzheimer’s disease

Alzheimer's & dementia, 2021-12, Vol.17 (S9), p.n/a

2021

Volltextzugriff (PDF)

Concordance of CSF biomarkers with amyloid PET at baseline in EMERGE/ENGAGE, phase 3 studies of aducanumab in patients with early Alzheimer’s disease

Alzheimer's & dementia, 2022-12, Vol.18 (S6), p.n/a

2022

Volltextzugriff (PDF)

Investigating the neuroimmunogenic architecture of schizophrenia

Molecular psychiatry, 2018-05, Vol.23 (5), p.1251-1260

2018

Volltextzugriff (PDF)

Evaluation of common gene expression patterns in the rat nervous system

Physiological genomics, 2003-12, Vol.16 (1), p.1-7

2003

Volltextzugriff (PDF)

Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child and Adolescent Psychiatry, 2010-09, Vol.49 (9), p.884-897

2010

Volltextzugriff (PDF)

5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium

The Journal of pharmacology and experimental therapeutics, 2004-05, Vol.309 (2), p.825

2004

Volltextzugriff (PDF)

Investigating the Contribution of Common Genetic Variants to the Risk and Pathogenesis of ADHD

The American journal of psychiatry, 2012-02, Vol.169 (2), p.186-194

2012

Volltextzugriff (PDF)

Genomewide Association Studies: History, Rationale, and Prospects for Psychiatric Disorders

The American journal of psychiatry, 2009-05, Vol.166 (5), p.540-556

2009

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(69)
Dissertationen
(1)

Sprache

Englisch
(69)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(39)
Science & Technology
(39)
Male
(24)
Animals
(23)
Humans
(20)
Neurosciences
(19)
Neurosciences & Neurology
(19)
Biological And Medical Sciences
(16)
Rats
(16)
Female
(14)
Adult
(9)
Psychiatry
(9)
Rats, Sprague-Dawley
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Medical Sciences
(8)
Middle Aged
(8)
Adolescent
(7)
Biochemistry & Molecular Biology
(7)
Gene Expression
(7)
Aged
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab

Multiple Regulatory Variants Modulate Expression of 5-Hydroxytryptamine 2A Receptors in Human Cortex

A framework for translating tauopathy therapeutics: Drug discovery to clinical trials

CYP2D6 predicted metabolizer status and safety in adult patients with attention-deficit hyperactivity disorder participating in a large placebo-controlled atomoxetine maintenance of response clinical trial

Antipsychotic-induced gene regulation in multiple brain regions

The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus

Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia

Fast Fos: rapid protocols for single- and double-labeling c-Fos immunohistochemistry in fresh frozen brain sections

Modulation of neurotransmitter release in orexin/hypocretin-2 receptor knockout mice: A microdialysis study

Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates

Subgroup Analyses of the Amyloid PET Substudies From EMERGE and ENGAGE, Phase 3 Clinical Trials Evaluating Aducanumab in Patients With Early Alzheimer’s Disease (P1-1.Virtual)

Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex

CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab

Reductions in Biomarkers of Alzheimer’s Disease Pathophysiology Following Treatment With Aducanumab Were Associated With Slowing in Clinical Decline (P1-1.Virtual)

Phencyclidine-induced changes in rat cortical gene expression identified by microarray analysis: implications for schizophrenia

Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine

Subgroup analyses of the amyloid PET substudies from EMERGE and ENGAGE, phase 3 clinical trials evaluating aducanumab in patients with early Alzheimer’s disease

Concordance of CSF biomarkers with amyloid PET at baseline in EMERGE/ENGAGE, phase 3 studies of aducanumab in patients with early Alzheimer’s disease

Investigating the neuroimmunogenic architecture of schizophrenia

Evaluation of common gene expression patterns in the rat nervous system

Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder

5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium

Investigating the Contribution of Common Genetic Variants to the Risk and Pathogenesis of ADHD

Genomewide Association Studies: History, Rationale, and Prospects for Psychiatric Disorders

Suchergebnisse filtern